Free Access
Med Sci (Paris)
Volume 30, Number 4, Avril 2014
Page(s) 350 - 352
Section Nouvelles
Published online 05 May 2014
  1. Corti O, Lesage S, Brice A. What genetics tells us about the causes and mechanisms of Parkinson’s disease. Physiol Rev 2011 ; 91 : 1161–1218. [CrossRef] [PubMed] [Google Scholar]
  2. Mira MT, Alcaïs A, Nguyen VT, et al. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 2004 ; 427 : 636–640. [CrossRef] [PubMed] [Google Scholar]
  3. Narendra D, Tanaka A, Suen DF, Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 2008 ; 183 : 795–803. [CrossRef] [PubMed] [Google Scholar]
  4. Manzanillo PS, Ayres JS, Watson RO, et al. The ubiquitin ligase parkin mediates resistance to intracellular pathogens. Nature 2013 ; 501 : 512–516. [CrossRef] [PubMed] [Google Scholar]
  5. Berthier A. Un peu de Rose dans la maladie de Parkinson. Med Sci (Paris) 2008 ; 24 : 118–119. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  6. Corti O, Brice A. Mitochondrial quality control turns out to be the principal suspect in parkin and PINK1-related autosomal recessive Parkinson’s disease. Curr Opin Neurobiol 2013 ; 23 : 100–108. [CrossRef] [PubMed] [Google Scholar]
  7. Tang D, Kang R, Coyne CB, et al. PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev 2012 ; 249 : 158–175. [CrossRef] [PubMed] [Google Scholar]
  8. Tait SW, Green DR. Mitochondria and cell signalling. J Cell Sci 2012 ; 125 : 807–815. [CrossRef] [PubMed] [Google Scholar]
  9. De Léséleuc L, Orlova M, Cobat A, et al. PARK2 mediates interleukin 6 and monocyte chemoattractant protein 1 production by human macrophages. PLoS Negl Trop Dis 2013 ; 7 : e2015. e2017. [CrossRef] [PubMed] [Google Scholar]
  10. Greene JC, Whitworth AJ, Andrews LA, et al. Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis. Hum Mol Genet 2005 ; 14 : 799–811. [CrossRef] [PubMed] [Google Scholar]
  11. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology 1988 ; 38 : 1285–1291. [CrossRef] [PubMed] [Google Scholar]
  12. Hirsch EC, Hunot S. Neuroinflammation in Parkinson’s disease: a target for neuroprotection. Lancet Neurol 2009 ; 8 : 382–397. [CrossRef] [PubMed] [Google Scholar]
  13. Frank-Cannon TC, Tran T, Ruhn KA, et al. Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. J Neurosci 2008 ; 28 : 10825–10834. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.